Drugs / LCAR-C18S
last change Jul 2023 re-read 3 minutes ago

LCAR-C18S

Investigated by
Nanjing Legend Biotech Co. · Shanghai East Hospital

Trials 1

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT04467853 Sep 2020 → Jul 2023 — Shanghai East Hospital Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as LCAR-C18S ClinicalTrials.gov intervention name — accepted as the source's own label NCT04467853 ↗